Establishment of screening systems for evaluating drug actions in the kidney

建立评估肾脏药物作用的筛选系统

基本信息

  • 批准号:
    01870111
  • 负责人:
  • 金额:
    $ 7.87万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1991
  • 项目状态:
    已结题

项目摘要

l. Characteristies of nephron heterogeneity supporting screening systems tor the evaluation of renal drug actions.The results obtained include nephron energy metabolism, localization of purine-metabolizing enzymes, inhibitory effect of CAMP on superoxide generation in gloseruli, biphasic increasing effect of angiotensin I]on cytosolic calcium transient in early proximal tubule, a novel vasopressin receptor in the proximal tubule, localization of glycine avidinotransferase within the kidney, lipid peroxidation in rat nephron segments, and intrarenal handling of proteins in rats.2. Screening systems for the evaluation of kidney-acting drugs.Intrarenal sites of PGE2 production are highly heterogeneous, and loop diuretics increase PGE2 accuiu'ation selectively in the thick ascending limb suggesting PGE2 as a possible physiological mediator to cause diuresis. Furosemide also acts on short loop of descending thin limb, but not on Ions loop, that could be concluded by determining ATP turnover … More using isolated nephron seg2ents. Antinephrotic drugs potentiate adenosine action on glo2eruli which is well correlated with 'suppressive effect on free radical formation. Estimation of intranephron lipid peroxidation makes it possible to identify the early proximal tubule as a causative site of early stage in diabetic nephropathy. Frog urinary bladde can be used to identify intra cellular nechanislis of renal drug action especially on sodium ion transport coupled with protein kinase C.3. Screening systems for the evaluation of nephrotoxicity.Intracellular ATP turnover and agonist-induced cytosolic free calcium transients are sensitive and useful determinants to quantify nephrotoxicity along the nephron. Metabolic functions such as renal gluconeogenesis and ammoniagenesis can be used to find very early signs of nephrotoxicity prior to histological alterations.The above-summarized results can not only classify kidney-acting and nephrotoxic drugs, but also bring notable informations for the better understanding nechanisums of these drug actions. Less
L.肾单位异质性的特征支持了肾脏药物作用评价的筛选系统,所获得的结果包括肾单位能量代谢、嘌呤代谢酶的定位、cAMP对肾小球中超氧化物生成的抑制作用、血管紧张素I对早期近曲小管胞浆钙瞬变的双相增加作用、近曲小管中的一种新的加压素受体、甘氨酸抗生物素蛋白转移酶在肾脏内的定位,大鼠肾单位节段中的脂质过氧化,以及大鼠肾内蛋白质的处理。肾内产生PGE2的位点是高度异质的,袢利尿剂选择性地增加了在粗的上行支中的PGE2聚集,这表明PGE2是引起利尿的可能的生理介质。速尿也作用于下行细肢短袢,但不作用于离子袢,这可通过测定ATP周转率得出结论 ...更多信息 使用分离的肾单位片段。抗肾上腺素药物加强腺苷对肾小球的作用,这与抑制自由基形成密切相关。肾内脂质过氧化反应的评估使早期近端小管作为糖尿病肾病早期的致病部位成为可能。蛙膀胱可用于鉴定肾脏药物作用的细胞内机制,尤其是钠离子转运与蛋白激酶C偶联的机制。评价肾毒性的筛选系统细胞内ATP周转和激动剂诱导的胞浆游离钙瞬变是量化肾毒性沿着肾单位的敏感和有用的决定因素。代谢功能如肾再生和产氨作用可在组织学改变之前发现肾毒性的早期征象,这不仅可将肾作用药物和肾毒性药物分类,而且为更好地理解这些药物作用的机理提供了重要信息。少

项目成果

期刊论文数量(162)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Jung, K. Y. and Endou, H.: "Nephrotoxicity assessment by measuring cellular ATP content II. Intra-nephron site of ochrratoxin A nephrotoxicity." Toxicol. Appl. Pharmacol.100. 383-390 (1989)
Jung, K. Y. 和 Endou, H.:“通过测量细胞 ATP 含量进行肾毒性评估 II。赭曲霉毒素 A 肾毒性的肾单位内位点。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyanoshita, A., Takahashi, T. and Endou, H.: "Inhibitory effect of cyclic AMP on phorbol estere stimulated production of reactive oxygen metabolites in rat glomeruli." Biochem. Biophys. Res. Commun.165(1). 519-525 (1989)
Miyanoshita, A.、Takahashi, T. 和 Endou, H.:“环 AMP 对佛波酯的抑制作用刺激了大鼠肾小球中活性氧代谢物的产生。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Miyanoshita, A., Terada, M. and Endou, H.: "Furosemide directly stimulates prostaglandin E_2 production in the thick ascending limbof Henle's loop" J. Pharmacol. Exp. Ther.251(3). 1155-1159 (1989)
Miyanoshita, A.、Terada, M. 和 Endou, H.:“呋塞米直接刺激亨利氏袢厚升肢中前列腺素 E_2 的产生”J. Pharmacol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoh, T. and Endou, H.: "Inhibitory effect of phorbol ester on sodium transport in frog urinary bladder." Am. J. Physiol.259. F425-F431 (1990)
Satoh, T. 和 Endou, H.:“佛波酯对青蛙膀胱钠转运的抑制作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Endou,H.et al.: "Adenosine 2 receptor distribution along the rat nephron and its role in generation of oxygen metabolites in glomeruli" The frontiers of Nephrology. (1990)
Endou, H. 等人:“腺苷 2 受体沿大鼠肾单位的分布及其在肾小球中氧代谢物生成中的作用”肾脏病学前沿。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ENDOU Hitoshi其他文献

ENDOU Hitoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ENDOU Hitoshi', 18)}}的其他基金

Development of novel anti-uricosuric agents based on the genomic strategy.
基于基因组策略开发新型抗尿酸排泄药物。
  • 批准号:
    14207004
  • 财政年份:
    2002
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Genetic Abnormality of Renal Proximal Tubule-Specific Transporters as Causes of Sudden Death Syndrome in South-Eastern Asia
肾近端小管特异性转运蛋白的遗传异常是东南亚猝死综合症的原因
  • 批准号:
    13376004
  • 财政年份:
    2001
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Identification of transporter genes regulating systemic kinetics of drugs and foreign compounds and their genetic polymorphism
调节药物和外来化合物全身动力学的转运蛋白基因的鉴定及其遗传多态性
  • 批准号:
    12357016
  • 财政年份:
    2000
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of drug transport across cell membrane
药物跨细胞膜转运的分子机制
  • 批准号:
    11694310
  • 财政年份:
    1999
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular cloning and functional expression of kidney-specific organic anionic drug transporters
肾脏特异性有机阴离子药物转运蛋白的分子克隆及功能表达
  • 批准号:
    09470025
  • 财政年份:
    1997
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of vanadium in endemic diseases in Northeast Thailand
钒在泰国东北部地方病中的作用
  • 批准号:
    07041167
  • 财政年份:
    1995
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
Establishment of immotalized cell lines from transgenic mouse nephron segments
从转基因小鼠肾单位片段建立永生化细胞系
  • 批准号:
    04557122
  • 财政年份:
    1992
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
Endemic Primary Distal Renal Tubular Acidosis in Thailand
泰国地方性原发性远端肾小管酸中毒
  • 批准号:
    04041041
  • 财政年份:
    1992
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for international Scientific Research
ULTRAMICRO METHODS FOR DETERMINING ENZYME ACTIVITIES AND SUBSTRATES USING COMBINED BIOLUMINESCENT ASSAY WITH ENZYMATIC CYCLING
使用生物发光测定与酶循环相结合测定酶活性和底物的超微方法
  • 批准号:
    62870009
  • 财政年份:
    1987
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
Intrarenal actions of atrial natriuretic peptides
心房钠尿肽的肾内作用
  • 批准号:
    61570094
  • 财政年份:
    1986
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了